← Back to headlines
David Einhorn Likes Teva Pharmaceutical Stock
Investor David Einhorn has shown a favorable opinion towards Teva Pharmaceutical (TEVA) stock, suggesting a positive view on the pharma company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Man Seriously Injured After Disco Ball Falls at Copenhagen Company Party
28m ago
U.S. Issues Health Alert Amid Cuba’s Worsening Infrastructure Crisis
33m ago
Russia Launches Drone Strikes on Kyiv Security Headquarters and Mykolaiv Mall
33m ago
Trump Threatens Strike on Iran Nuclear Site Amid Shifting Middle East Posture
35m ago